Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Medmix share down 76% since investment five years ago

If someone had invested 1,000 CHF in Medmix five years ago, they would now own 22.941 shares worth 239.96 CHF at a price of 10.46 CHF (as of 27.10.2026), corresponding to a negative performance of 76.00%. Medmix's market capitalization most recently stood at CHF 426.06 million; the share was first traded on 30.09.2021 at CHF 45.00. Calculation does not take into account any stock splits or dividends. » More on finanzen.net
Medmix share: investment from three years ago loses 51.3%

Someone who bought 100 CHF of Medmix shares three years ago (closing price then 20.70 CHF) now owns 4.831 shares worth 48.70 CHF at a last price of 10.08 CHF, representing a loss of 51.30%. Medmix’s market value was most recently 414.21 million CHF. The Medmix share went public on 30 September 2021; the first price was 45.00 CHF. Stock splits and dividends are not taken into account in the calculation. » More on finanzen.net
Medmix stock achieves 12.10% return over one year

Had CHF 10,000 been invested in Medmix at the close on 14 October 2025 (closing price CHF 8.76), the portfolio would now hold 1,141.553 shares. At a price of CHF 9.82 on 13 October 2026 the value would be CHF 11,210.05, corresponding to a gain of 12.10%. Medmix was most recently valued at CHF 396.39 million; stock splits and dividends are not included in the calculation. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics

In 2026, MEDMIX AG NAM. SF -,01 Aktie has already paid €0.11 in dividends. The last payout was in April.

Financials

In the last quarter, MEDMIX AG NAM. SF -,01 Aktie had revenue of €232.27m and net profit of €541.68k

(EUR)	June 2026	YoY
Revenue	232.27m	-
Gross profit	87.86m	-
Net profit	541.68k	-
EBITDA	44.74m	-

Fundamentals

Metric	Value
Market capitalization	€462.49m
Number of shares	40.71m
52-week high/low	€13.45 - €8.28
Dividend yield	0.97%
Dividends TTM	€0.11
Beta	0.77
P/E ratio	4,176.00
PEG ratio	-43.92
P/B ratio	1.00
P/S ratio	0.97

Company profile

Medmix AG designs, develops, manufactures, and delivers high-precision devices and services for the mixing, application, and injection of liquids in a range of viscosities for the healthcare, consumer, and industrial end markets worldwide. It operates through five segments: Dental, Drug Delivery, Surgery, Industry, and Beauty. The Dental segment offers mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, restorations, anesthetics, and aesthetics. The Drug Delivery segment offers drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases. The Surgery segment provides mixing and delivery devices which are used to inject bone cement, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. The Industry segment produces and markets dispensers, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics, infrastructure, and general industrial sectors. The Beauty segment offers micro brushes, mascara, lip gloss and concealers. The company offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Zug, Switzerland.